FIELD: pharmacology.
SUBSTANCE: invention relates to a method for preparation of a compound of the formula
and intermediates used to implement the method, as well as a method for pregabalin preparation.
EFFECT: method can be implemented on a commercial scale using readily available, safe raw materials and reagents, and without the need for difficult separations.
20 cl, 8 tbl, 41 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING (S)-3-AMINOMETHYL-5-METHYLHEXANOIC ACID (PREGABALIN) | 2013 |
|
RU2544859C1 |
NOVEL COMPOUNDS POSSESSING ANTI-INFLAMMATORY ACTIVITY AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF | 2001 |
|
RU2288225C2 |
METHOD OF PRODUCING (S)-3-AMINOMETHYL-5-METHYLHEXANOIC ACID | 2015 |
|
RU2643373C2 |
PYRAZOLE PYRIDINE DERIVATIVES AS NADPH-OXIDASE | 2009 |
|
RU2548022C2 |
PHARMACEUTICAL AGENT CONTAINING INHIBITOR OF SODIUM-DEPENDENT PHOSPHATE CARRIER | 2015 |
|
RU2740008C2 |
IMIDAZOPYRIDAZINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2679609C1 |
COMPOUNDING, WHICH INHIBITES ACTIVITY OF BTK AND/OR JAK3 KINASES | 2014 |
|
RU2650512C2 |
CYCLIC INHIBITORS OF 11BETA-HYDROXYSTEROID-DEHYDROGENASE 1 | 2009 |
|
RU2531272C2 |
PHARMACEUTICAL PRODUCT CONTAINING INHIBITOR OF SODIUM DEPENDENT PHOSPHATE CARRIER | 2015 |
|
RU2811864C1 |
COMBINATIONS OF ALPHA-2-DELTA-LIGAND WITH SELECTIVE CYCLOIXYGENASE-2 INHIBITOR | 2003 |
|
RU2286151C2 |
Authors
Dates
2017-08-15—Published
2014-03-25—Filed